Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Oct 13, 2009


NuGen Technologies has hired Christopher Raymond to lead a new research facility in Seattle that will focus on developing new sample-prep products for next-generation sequencing. Raymond joins the company from former Merck subsidiary Rosetta Inpharmatics, where he developed new technologies for whole-transcriptome profiling, targeted resequencing, and for the analysis of next-gen sequencing data.

The Broad Institute of MIT and Harvard last week announced the members of its first board of directors.

Members of the board, who are appointed for three years, are Dennis Ausiello, chief of medicine at Massachusetts General Hospital; David Baltimore, president emeritus at the California Institute of Technology; Eli Broad, founder of the Broad Foundations; Drew Gilpin Faust, president of Harvard University; Jeffrey Flier, dean of the faculty of medicine at Harvard Medical School; Susan Hockfield, president of the Massachusetts Institute of Technology; Seth Klarman, president of the Baupost Group; Eric Lander, president and director of the Broad Institute and professor at MIT and Harvard Medical School; William Lee, co-managing partner at WilmerHale; Arthur Levinson, chairman at Genentech; Phillip Sharp, professor at MIT; Patty Stonesifer, former president of the Bill & Melinda Gates Foundation and senior advisor to the trustees of the foundation; Ratan Tata, chairman of the Tata Group; and Diana Chapman Walsh, president emerita of Wellesley College.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.